DP
BIOA

Diadema Partners’s BioAge Labs BIOA Stock Holding History

Diadema Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Buy
146,334
+86,334
+144% +$1.56M 0.45% 56
2026
Q1 		$1.05M Sell
60,000
-211,164
-78% -$4.07M 0.18% 84
2025
Q4 		$3.59M Buy
+271,164
New +$2.4M 0.62% 40

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Diadema Partners's BIOA Position: Q2 2026 in Review

Diadema Partners increased its BioAge Labs (BIOA) stake by 144% in Q2 2026, buying an estimated $1.56M and bringing the position to 146,334 shares worth $3.59M. The position accounts for 0.45% of the portfolio, ranked #56.

Diadema Partners first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.59M in Q4 2025. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Diadema Partners held 146,334 shares of BioAge Labs worth $3.59M as of Q2 2026.
  • Diadema Partners bought 86,334 BioAge Labs shares in Q2 2026, an estimated $1.56M.
  • BioAge Labs made up 0.45% of Diadema Partners's portfolio in Q2 2026, its #56 holding.
  • Diadema Partners first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
  • Diadema Partners's BioAge Labs position peaked at $3.59M in Q4 2025.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.